PURA VIDA INVESTMENTS, LLC
NEW YORK, NY · CIK 1590144 · 13F filing filed 2022-08-15
SEC-registered investment adviser since 2014 · limited liability company
- Assets managed$91.5m
- Staff2 · 1 in investment roles
- Main clients (by assets)Private funds 57%
- Private funds3 (2 hedge) · $52.5m gross assets
- Websitepuravidainvestments.com
- Form ADV · 2026-03-30SEC adviser record
- Legal entityPURA VIDA INVESTMENTS, LLC (US)
- Kindhedge funds, private equity, futures
- Others nearbyNew York, NY
As an employer
- Offices in1 country
- Private fundsprivate equity 1, hedge 2
US visa salary filings
- Filings FY20241
- Median salary offered$175,000
- Middle half$175,000 – $175,000
- Job titles1
| Job title | Filings | Median |
|---|---|---|
| Capital Markets AnalystNew York, NY | 1 | $175,000 |
Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Pura Vida Investments, LLC.
Options: 44 call positions ($348.8m notional), 55 put positions ($743.9m notional) – listed below, not included above.
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ESTABLISHMENT LABS HLDGS INC ESTA | $53.8m8.55% | Added +26.2k |
| CUTERA INC CUTR | $41.9m6.67% | Added +44.0k |
| INSPIRE MED SYS INC INSP | $37.4m5.94% | Added +1.0k |
| VIEWRAY INC VRAYQ | $36.8m5.84% | Added +307.3k |
| GLAUKOS CORP GKOS | $36.2m5.75% | New |
| BIOGEN INC BIIB | $20.7m3.30% | Reduced -45.4k |
| PULMONX CORP LUNG | $19.5m3.10% | Added +737.3k |
| GUARDANT HEALTH INC GH | $18.9m3.01% | Added +401.1k |
| NANOSTRING TECHNOLOGIES INC NSTG | $18.7m2.97% | Added +249.2k |
| ONCOCYTE CORP COM | $16.2m2.58% | Added +5.8m |
| LIVANOVA PLC LIVN | $16.0m2.55% | Reduced -90.7k |
| LYRA THERAPEUTICS INC LYRA | $14.6m2.31% | Added +2.1m |
| UNITED THERAPEUTICS CORP DEL UTHR | $14.3m2.27% | Added +44.1k |
| LANTHEUS HLDGS INC LNTH | $14.0m2.23% | Reduced -10.0k |
| ALNYLAM PHARMACEUTICALS INC ALNY | $13.9m2.21% | New |
| STAAR SURGICAL CO STAA | $13.9m2.21% | Reduced -264 |
| ASTRAZENECA PLC SPONSORED ADR | $10.8m1.71% | Added +132.8k |
| COOPER COS INC COM NEW | $10.2m1.62% | Added +19.5k |
| CYTOKINETICS INC CYTK 4 11.15.26 · principal | $9.7m1.54% | Unchanged |
| SOMALOGIC INC SLGC | $9.6m1.53% | Reduced -352.7k |
| KALVISTA PHARMACEUTICALS INC KALV | $8.0m1.27% | Added +771.4k |
| APYX MEDICAL CORPORATION APYX | $7.8m1.23% | Added +340.6k |
| QUANTERIX CORP QTRX | $7.1m1.13% | New |
| EVOLENT HEALTH INC EVH | $7.1m1.12% | Added +30.0k |
| IVERIC BIO INC OPHT | $6.9m1.09% | Reduced -150.0k |
| OUTSET MED INC OM | $6.6m1.05% | Reduced -31.2k |
| 908 DEVICES INC MASS | $6.1m0.97% | Unchanged |
| MILESTONE PHARMACEUTICALS IN MIST | $6.1m0.97% | Unchanged |
| IRHYTHM TECHNOLOGIES INC IRTC | $5.4m0.86% | New |
| R1 RCM INC COM | $5.2m0.83% | New |
| PRIVIA HEALTH GROUP INC PRVA | $5.2m0.83% | Reduced -61.9k |
| AGILON HEALTH INC COM | $5.2m0.82% | Added +191.1k |
| CYTEK BIOSCIENCES INC CTKB | $5.1m0.81% | Added +52.6k |
| AVANTOR INC AVTR | $4.8m0.77% | New |
| VERTEX PHARMACEUTICALS INC VRTX | $4.7m0.75% | Reduced -67.3k |
| ATRICURE INC ATRC | $4.4m0.69% | Reduced -230.0k |
| BIOVENTUS INC BVS | $4.1m0.65% | Added +43.2k |
| TG THERAPEUTICS INC TGTX | $4.0m0.64% | Added +622.6k |
| TRAVERE THERAPEUTICS INC TVTX | $4.0m0.64% | Added +56.0k |
| THE BEAUTY HEALTH COMPANY COM CL A | $3.9m0.62% | New |
| TELA BIO INC TELA | $3.9m0.62% | Reduced -11.8k |
| BIOCRYST PHARMACEUTICALS INC BCRX | $3.9m0.61% | New |
| KARUNA THERAPEUTICS INC COM | $3.8m0.60% | New |
| CODEXIS INC CDXS | $3.5m0.56% | Reduced -128.7k |
| AVITA MEDICAL INC RCEL | $3.5m0.56% | Added +67.6k |
| JAZZ PHARMACEUTICALS PLC JAZZ | $3.4m0.54% | New |
| SOPHIA GENETICS SA SOPH | $3.1m0.49% | Added +30.0k |
| BICYCLE THERAPEUTICS PLC BCYC | $3.1m0.49% | New |
| HUMANA INC HUM | $3.0m0.48% | New |
| ICAD INC ICAD | $2.7m0.43% | Unchanged |
| ATAI LIFE SCIENCES NV ATAI | $2.6m0.42% | Reduced -556.3k |
| SCIENCE 37 HOLDINGS INC COM | $2.2m0.35% | Added +100.0k |
| NYXOAH S A NYXH | $2.2m0.35% | Unchanged |
| INSULET CORP PODD | $2.2m0.35% | New |
| COGENT BIOSCIENCES INC COGT | $2.2m0.34% | New |
| NATERA INC NTRA | $2.1m0.34% | New |
| ARCUTIS BIOTHERAPEUTICS INC ARQT | $2.1m0.34% | Reduced -89.4k |
| ALPHA TEKNOVA INC TKNO | $2.1m0.34% | Unchanged |
| GH RESEARCH PLC GHRS | $2.1m0.33% | Unchanged |
| PTC THERAPEUTICS INC PTCT 3 08.15.22 · principal | $2.0m0.32% | New |
| EDWARDS LIFESCIENCES CORP EW | $2.0m0.31% | New |
| AMYRIS INC AMRS | $1.9m0.31% | Reduced -1.4m |
| AVADEL PHARMACEUTICALS PLC SPONSORED ADR | $1.9m0.31% | New |
| SONENDO INC COM | $1.8m0.28% | Unchanged |
| QUOTIENT LTD SHS | $1.6m0.25% | Reduced -3.5m |
| EXELIXIS INC EXEL | $1.6m0.25% | New |
| APOLLO ENDOSURGERY INC COM | $1.6m0.25% | Unchanged |
| STANDARD BIOTOOLS INC LAB | $1.4m0.22% | Unchanged |
| ESPERION THERAPEUTICS INC NE ESPR | $1.3m0.21% | New |
| SCHRODINGER INC SDGR | $1.3m0.21% | Unchanged |
| LUCIRA HEALTH INC COM | $1.3m0.20% | Added +3.5k |
| VIRIDIAN THERAPEUTICS INC VRDN | $1.2m0.19% | Unchanged |
| XENON PHARMACEUTICALS INC XENE | $1.2m0.19% | Added +25.0k |
| ADAPTIVE BIOTECHNOLOGIES COR ADPT | $1.2m0.19% | Unchanged |
| VERASTEM INC COM | $1.2m0.19% | New |
| BELLUS HEALTH INC NEW BLU | $1.1m0.18% | Reduced -268.1k |
| MEDAVAIL HOLDINGS INC MYOS | $1.1m0.17% | Unchanged |
| HEALTH SCIENCES ACQ CORP 2 OBIO | $1.0m0.16% | Unchanged |
| HORIZON THERAPEUTICS PUB L HZNP | $1.0m0.16% | New |
| PHATHOM PHARMACEUTICALS INC PHAT | $864.0k0.14% | Unchanged |
| ATHIRA PHARMA INC COM | $818.0k0.13% | Reduced -71.3k |
| CHIMERIX INC CMRX | $801.0k0.13% | New |
| STRYVE FOODS INC CLASS A COM | $705.0k0.11% | New |
| GOSSAMER BIO INC GOSS | $677.0k0.11% | Reduced -7.1k |
| TRAVERE THERAPEUTICS INC TVTX 2.25 03.01.29 · principal | $502.0k0.08% | Unchanged |
| TRICIDA INC TCDA | $483.0k0.08% | Reduced -130.9k |
| GLOBAL BLOOD THERAPEUTICS IN GBT | $462.0k0.07% | Reduced -15.0k |
| GOSSAMER BIO INC GOSS 5 06.01.27 · principal | $374.0k0.06% | Unchanged |
| RENOVACOR INC COM | $294.0k0.05% | Reduced -465 |
| IMMUNOCORE HLDGS PLC IMCR | $239.0k0.04% | New |
| ZYMEWORKS INC ZYME | $237.0k0.04% | New |
| AMYLYX PHARMACEUTICALS INC AMLX | $203.0k0.03% | Added +550 |
| UNITY BIOTECHNOLOGY INC UBXGB | $202.0k0.03% | Reduced -1.2m |
| CONCERT PHARMACEUTICALS INC CNCE | $187.0k0.03% | New |
| SOMALOGIC INC *W EXP 08/31/202 | $155.0k0.02% | Unchanged |
| UNIVERSE PHARMACEUTICALS INC SHS | $150.0k0.02% | Reduced -840.0k |
| TALKSPACE INC TALKW | $149.0k0.02% | Unchanged |
| SAVARA INC SVRA | $144.0k0.02% | Unchanged |
| VINCERX PHARMA INC COM NEW | $143.0k0.02% | Unchanged |
| ROIVANT SCIENCES LTD *W EXP 09/30/202 | $120.0k0.02% | Unchanged |
Sold out since Q1 2022
| Security | Value then |
|---|---|
| C4 THERAPEUTICS INC CCCC | $15.2m624.9k shares |
| BIOMARIN PHARMACEUTICAL INC BMRN | $13.5m175.4k shares |
| ICU MED INC ICUI | $12.8m57.7k shares |
| CONVEY HEALTH SOLUTIONS HLDG | $11.3m1.7m shares |
| BIO-TECHNE CORP TECH | $10.8m25.0k shares |
| IMMUNIC INC | $7.7m683.3k shares |
| INTELLIA THERAPEUTICS INC NTLA | $7.6m104.1k shares |
| STEREOTAXIS INC STXS | $5.5m1.5m shares |
| R1 RCM INC RCM | $5.0m188.5k shares |
| CELLDEX THERAPEUTICS INC NEW CLDX | $4.5m132.6k shares |
| GREENLIGHT BIOSCIENCS HLDS P | $3.9m400.0k shares |
| PELOTON INTERACTIVE INC PTON | $2.1m80.0k shares |
| SAREPTA THERAPEUTICS INC SRPT | $2.0m25.9k shares |
| LIQUIDIA CORPORATION LQDA | $1.8m251.6k shares |
| MERUS N V MRUS | $1.8m66.5k shares |
| 10X GENOMICS INC TXG | $1.7m22.3k shares |
| DA32 LIFE SCNCE TEC ACQSTN C | $1.6m164.8k shares |
| PROTAGONIST THERAPEUTICS INC PTGX | $1.5m65.4k shares |
| CHINOOK THERAPEUTICS INC ADRO | $1.4m85.2k shares |
| WM TECHNOLOGY INC MAPS | $1.4m178.0k shares |
| ADICET BIO INC | $1.3m66.6k shares |
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $1.3m11.0k shares |
| NAUTILUS BIOTECHNOLOGY INC NAUT | $1.1m244.7k shares |
| CYCLERION THERAPEUTICS INC | $862.0k776.5k shares |
| CORVUS PHARMACEUTICALS INC CRVS | $813.0k495.5k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| ISHARES TR Put | $118.6m700.0k shares | Reduced |
| BIOGEN INC BIIB · Call | $71.2m348.9k shares | Unchanged |
| STRYKER CORPORATION SYK · Put | $58.7m295.0k shares | Added |
| ISHARES TR Put | $58.0m1.1m shares | Reduced |
| LIVANOVA PLC LIVN · Call | $54.3m869.1k shares | Added |
| SPDR SER TR Put | $37.1m500.0k shares | Reduced |
| FIRST TR EXCHANGE TRADED FD Put | $34.0m330.0k shares | Added |
| IDEXX LABS INC IDXX · Put | $29.8m85.0k shares | New |
| ARK ETF TR ARKG · Put | $26.8m850.0k shares | Reduced |
| MEDTRONIC PLC MDT · Put | $24.2m270.0k shares | Reduced |
| VANECK ETF TRUST Put | $23.1m300.0k shares | New |
| ABBOTT LABS ABT · Put | $21.7m200.0k shares | Added |
| METTLER TOLEDO INTERNATIONAL MTD · Put | $20.1m17.5k shares | Added |
| GUARDANT HEALTH INC GH · Call | $18.8m465.0k shares | Added |
| ARK ETF TR ARKK · Put | $17.9m450.0k shares | Reduced |
| CELLDEX THERAPEUTICS INC NEW CLDX · Call | $16.0m594.8k shares | Added |
| PERKINELMER INC RVTY · Put | $15.6m110.0k shares | New |
| PENUMBRA INC PEN · Put | $15.6m125.0k shares | New |
| BRISTOL-MYERS SQUIBB CO Put | $15.4m200.0k shares | New |
| HEALTHEQUITY INC HQY · Call | $15.3m250.0k shares | Added |
| PRIVIA HEALTH GROUP INC PRVA · Call | $15.3m525.0k shares | Added |
| SAREPTA THERAPEUTICS INC SRPT · Call | $15.0m200.0k shares | Unchanged |
| MOLSON COORS BEVERAGE CO TAP · Put | $14.1m258.3k shares | Added |
| ALIGN TECHNOLOGY INC ALGN · Put | $13.0m55.0k shares | New |
| BIONTECH SE BNTX · Call | $11.9m80.0k shares | New |
Trades reported as a company insider in Q2 2022
Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.
| Date | Company | Trade | Value |
|---|---|---|---|
| 2022-06-24 | INSIGHT MOLECULAR DIA INC 10% owner · By the Managed Accounts. | Sold | $54.8k53.0k shares |
| 2022-06-24 | INSIGHT MOLECULAR DIA INC 10% owner · By Pura Vida Master Fund, Ltd. | Sold | $48.0k46.4k shares |
| 2022-04-14 | INSIGHT MOLECULAR DIA INC 10% owner · By Pura Vida Master Fund, Ltd. | Bought | $154.3k123.2k shares |
| 2022-04-14 | INSIGHT MOLECULAR DIA INC 10% owner · By the Managed Accounts. | Bought | $96.2k76.8k shares |